Latest treatment News | Page 173

Final GP Respiratory Clinics To Transition To GP Clinics
Growth of aesthetic and beauty industry in Australia
How to launch your own beauty business
Top performing ASX life science companies 26 October
Council records big year of infrastructure projects
Western NSW patients rate cancer care highly
Launch of Aboriginal and Torres Strait Islander Cancer Plan
Community tip-off sees 87 cats seized from appalling conditions at Brimbank property
Residents are encouraged to watch water usage due to extreme heat
Wounding chargesin Brisbane
WHO calls for immediate release, access to, and medical support for hostages taken by Hamas
Police seek help to find missing man at Herston 26 October
Better safe than scary this Halloween
Elective surgery and outpatient waiting times down, again
Breast cancer survivor tells her story to help fellow firefighters
Gene link to female infertility
Outstanding results for Nepean Cancer and Wellness Centre
Prevent parasite impacts on your pig herd health
Translation of best practice for knee pain
Police investigate injuries to man at Christies Beach
Police arrest man after Pascoe Vale affray
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
Positive efficacy result for Immutep’s ‘efti’ in combination with MSD’s pembrolizumab
New research has found an existing drug could help many people with painful hand osteoarthritis
Watagans National Park partially reopens after bushfires and campfire scare
Ground-breaking research showcased at SALHN’s Research Week
Support for heavy gamblers through family intervention
Police investigate affray in Pascoe Vale
Datopotamab deruxtecan improved progression-free survival vs. chemotherapy in patients with previously treated non-small cell lung cancer in TROPION-Lung01 Phase III trial
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Datopotamab deruxtecan significantly extended progression-free survival vs. chemotherapy in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial
Police appeal to locate man missing from Kogarah 23 October
Anna Boltong Appointed As Ovarian Cancer Australia CEO
Enhertu approved in the EU as the first HER2-directed therapy for patients with HER2-mutant advanced non-small cell lung cancer
New solar and energy efficient upgrades for Ulladulla Civic Centre
Delivering life-saving training skills
Further appeal for information following shooting – Gateshead
Life changing gene therapy for babies with spinal muscular atrophy
Police seek help to find missing man at Woolloongabba 22 October
Datopotamab deruxtecan plus Imfinzi demonstrated robust and durable tumour responses in 1st-line treatment of patients with metastatic triple-negative breast cancer in BEGONIA…
Police investigating wounding incident at West End
Imfinzi plus chemotherapy more than doubled pathologic complete response rate in resectable early-stage gastric and gastroesophageal junction cancers versus chemotherapy alone
Strength in diversity – computing healthy microbiome relationships
Arrerst – Assault in Darwin
RALLY4EVER and Mood Active Join Forces to Ace Mental Health: A Unique Tennis Charity Fundraiser in Coogee
Human Rights Act must overcome inadequate patchwork of laws
Lockier serious crash
Helping Australians mentally prepare for bushfire season